Zili Xiao

591 citations
20 papers · 297 indexed · h-index 10
Topics
Multiple Myeloma Research and Treatments (4 papers)Cancer Treatment and Pharmacology (4 papers)Quinazolinone synthesis and applications (3 papers)

In The Last Decade

Zili Xiao

20 papers receiving 282 citations

Peers

Zili Xiao
Comparison fields: 5 of 59
  • Organic Chemistry 179
  • Molecular Biology 129
  • Hematology 36
  • Oncology 29
  • Pharmacology 25
Replace Gary M. Karp with:
Gary M. Karp United States
Terrance J. Magoc United States
Clarke Taylor United States
Dao Lentz United States
William R. Cantrell United States
Deborah L. Volkots United States
Kenneth J. Wiggall United States
Pondy Murugappan Ramanujulu Singapore
Tomomi Noguchi Japan
Sai Kumar Chakka South Africa
Zili Xiao relative to Gary M. Karp United States Gary M. Karp's profile →
Citations per field
00.5×1.5×2.2×
Gary M. Karp · 1×
Citations per year

Countries citing papers authored by Zili Xiao

Since Specialization
Citations

This map shows the geographic impact of Zili Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zili Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zili Xiao more than expected).

Fields of papers citing papers by Zili Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zili Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zili Xiao. The network helps show where Zili Xiao may publish in the future.

Co-authorship network of co-authors of Zili Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Zili Xiao. A scholar is included among the top collaborators of Zili Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zili Xiao. Zili Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 5
4 4
5 7
6 11
7 12
8 1
9 5
10 2
11 13
12 3
13 20
14
Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.
10
15 21
16 34
17 12
18 54
19 74
20 5

About Zili Xiao

Zili Xiao is a scholar working on Hematology, Oncology and Organic Chemistry, having authored 20 papers that have together received 297 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Organic Chemistry (179 citations), Hematology (36 citations) and Toxicology (8 citations). Zili Xiao has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Pui‐Kai Li, Norman C. Waters, Zhiyu Li, Michael A. Ihnat, Jiandong Shi, Michael G. Yang, Zhigen Hu, Bulbul Pandit, Peng Li and Percy H. Carter. Their work appears in journals such as Langmuir, Journal of Medicinal Chemistry and Organic Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026